Securities Code: 002294 Securities Abbreviation: Sinovac Announcement No.: 2026-044 Shenzhen Sinovac Pharmaceutical Co., Ltd. Announcement on the Extension of the Second Lock-up Period of the Third Employee Stock Ownership Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and there are no false records, misleading statements, or material omissions.
Shenzhen Sinovac Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company" or "Sinovac") held the 42nd meeting of the Fourth Board of Directors on December 22, 2023, and the 2024 First Extraordinary General Meeting of Shareholders on January 8, 2024, which deliberated and approved the "Proposal on the Third Employee Stock Ownership Plan (Draft and Summary) of Shenzhen Sinovac Pharmaceutical Co., Ltd." and other related proposals. (See the "Third Employee Stock Ownership Plan (Draft)" and the "Announcement on the Resolutions of the 2024 First Extraordinary General Meeting of Shareholders" and other related documents disclosed on Juchao Information Network on December 23, 2023, and January 9, 2024, respectively.)
Based on confidence in the Company's future development prospects and recognition of its long-term value, the holders of the third employee stock ownership plan (hereinafter referred to as the "Current Employee Stock Ownership Plan") recently held a meeting of holders, which agreed to voluntarily extend the second lock-up period of the Current Employee Stock Ownership Plan by 12 months. The second lock-up period will be extended from the original expiration date of July 12, 2026, to July 12, 2027. This extension only applies to the second tranche of unlocking; all other aspects of the Current Employee Stock Ownership Plan remain unchanged. The relevant situation is hereby announced as follows:
I. Basic Information of the Current Employee Stock Ownership Plan